STAT3 and cancer: Many lines of compelling evidence support that hyperactivated STAT3 signaling is positively correlated with tumor progression, malignancy, recurrence, drug resistance, and a poor prognosis by increasing the metastatic potential and maintaining CSC properties of cancer cells [5,6,7,8,32,33].